Firm
The four-partner addition includes A&O Shearman’s former co-head of global IP litigation
A settlement involving Disney and another ruling concerning a lawyer’s request for access to documents were also among the big developments
Blank Rome’s launch in West Palm Beach, marked by the arrival of two IP partners, comes in response to rising demands from technology clients
Abion says it has brought on board Matt Serlin as its first US hire to meet client demand for ‘full circle’ trademark and domain name services
Recently published Special Focus articles
Recently published Special Focus articles
-
Sponsored by CASThe emerging trends and strategic approaches in intellectual property search and analytics are outlined in a CAS article that suggests how chemical industry stakeholders can strengthen patent programmes, empower R&D teams, and gain competitive insight -
Sponsored by Maiwald Intellectual PropertySenior Maiwald lawyers outline the strategy behind the firm’s recognition as EPO Proceedings Firm of the Year at the Managing IP EMEA Awards 2025 and discuss key developments in the European intellectual property space
-
Sponsored by Bugnion SpAVieri Canepele of Bugnion SpA examines a landmark Italian Supreme Court ruling on whether a patent co-owner may exploit a jointly owned invention without consent from fellow rights holders
-
Sponsored by Liu, Shen & AssociatesGuanyang Yao of Liu, Shen & Associates reviews several Chinese court rulings on standard-essential patent disputes, including Panasonic v Oppo, and the growing judicial focus on mediation and comparable licences over top-down rate setting
-
Sponsored by Wanhuida Intellectual PropertyWu Xiaohui of Wanhuida Intellectual Property examines how a recent CNIPA decision reinforces the need for a holistic inventive step assessment when evaluating pharmaceutical combination formulations involving active ingredients that are chemically reactive
-
Sponsored by Maiwald Intellectual PropertyAnnelie Wünsche of Maiwald Intellectual Property summarises the EU’s proposed update to the supplementary protection certificate system for medicinal products, highlighting key procedural shifts, the role of the EUIPO, and ongoing debate over the most suitable examining authority
